Zepbound contains tirzepatide, a dual GLP-1 and GIP receptor agonist, while semaglutide activates only the GLP-1 receptor
Monitor for hypoglycaemia when used with other glucose-lowering medications, particularly if experiencing unexplained sweating, tremor, confusion, or palpitations
Mehandru and Merad reviewed the many clinical manifestations of long-haul COVID, including systemic and musculoskeletal manifestations (chronic fatigue and fibromyalgia symptoms), psychiatric symptoms (insomnia, depression, anxiety, neurocognitive deficits), autonomic and cardiovascular, GIS and renal and respiratory manifestations [71]
Accordingly, meta-analyses found that the risk of MACE was lower among the GLP-1 RA group than among the control group, estimating a risk reduction between 12 and 14% ( TABLE 2 Overview of studies reporting on GLP-1 RAs and the risk of coronary events